Approval is not likely next week. If everything goes well and quickly with the Company's application it moves to the next phase. If the testing apparatus works it moves to the next phase. If it is safe to use and accurate we should be off to the races. I would think a minimum of 3 weeks would be the best case scenario and 2 to 3 months worse case scenario depending on the clinical data presented. Most likely in the middle. The FDA may need more data then what was presented, on that it is a toss up. What data are they submitting, lab data from contaminated blood samples, human trials or both?

Stock plays like this one are bewildering, and while some are inpatient with waiting for FDA approval stocks like this move on anticipation, as been exampled by watching the gyrations this month. Let's hope for a great April